Obesity Clinical Trials near Orlando, FL
34 studies for Obesity are recruiting at 69 sites within 50 miles of Orlando, Florida, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Obesity trials in the US or all trials near Orlando.
Recruiting now
Obesity studies enrolling near Orlando
- Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
NCT07575399
- Phase 3
- Ages 18 to 99 years
- Sex: All
Nearest sites: Clinical Neuroscience Solutions (Orlando, FL); Florida Institute for Clinical Research (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 5 sites within 50 mi
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459
- Phase 3
- Ages 18 to 99 years
- Sex: All
Nearest sites: AdventHealth Orlando (Orlando, FL); Orlando Health Heart Institute (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
NCT07752979
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest sites: Charter Research - Winter Park /ID# 281968 (Orlando, FL); Florida Institute For Clinical Research /ID# 282739 (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
NCT07567001
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Cardiovascular Institute of Orlando (Orlando, FL); Guardian Research Org LLC (Winter Park, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
NCT07684235
- Phase 3
- Ages 18 to 99 years
- Sex: All
Nearest sites: Clinical Neuroscience Solutions - Orlando (Orlando, FL); Combined Research Orlando Phase I IV (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
NCT07720271
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Clinical Neuroscience Solution (Orlando, FL); Florida Institute for Clinical Research, LLC (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
NCT07783802
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest sites: Florida Institute For Clinical Research, LLC (Orlando, FL); K2 Medical Research - Maitland (Maitland, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- The RESET System Pivotal Clinical Trial (Protocol Revision K)
NCT04101669
- Interventional
- Ages 22 to 65 years
- Sex: All
Nearest sites: Orlando Health (Orlando, FL); Optimal Research Sites (Orange City, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
NCT06143956
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest sites: Charter Research - Winter Park (Orlando, FL); Charter Research - Lady Lake (The Villages, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
NCT06937086
- Phase 3
- Ages 18 to 70 years
- Sex: All
Nearest sites: Digestive and Liver Center of Florida (Orlando, FL); Orlando Health (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
NCT06937099
- Phase 3
- Ages 18 to 70 years
- Sex: All
Nearest sites: Digestive and Liver Center of Florida (Orlando, FL); Orlando Health (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
NCT07533175
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Florida Institute for Clinical Research, LLC (Orlando, FL); Oviedo Medical Research, LLC (Oviedo, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
NCT07589608
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest sites: Charter Research - Winter Park (Orlando, FL); Charter Research - Lady Lake (The Villages, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
NCT07668414
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Florida Inst For Clin Res LLC (Orlando, FL); Oviedo Medical Research, LLC (Oviedo, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
NCT07684144
- Phase 3
- Ages 18 to 99 years
- Sex: All
Nearest sites: Florida Institute for Clinical Research (Orlando, FL); Conquest Research - Winter Park (Winter Park, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
NCT07794579
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Headlands Research Orlando (Orlando, FL); Oviedo Medical Research (Oviedo, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
NCT06602141
- Interventional
- Ages 18 to 45 years
- Sex: All
- Accepts healthy volunteers
Nearest site: AdventHealth Translational Research Institute (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
NCT07090005
- Interventional
- Ages 21 to 65 years
- Sex: All
Nearest site: Orlando Health, Inc. (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
NCT07339423
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Clinical Neuroscience Solution (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
NCT07464015
- Interventional
- Ages 5 to 11 years
- Sex: All
Nearest site: University of Central Florida (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
NCT07793929
- Phase 1
- Ages 18 to 85 years
- Sex: All
- Accepts healthy volunteers
Nearest site: Kailera Clinical Site (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
NCT07837973
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Clinical Neuroscience Solutions (Orlando, FL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
NCT07685808
- Phase 2
- Ages 18 years and older
- Sex: All
Nearest sites: Clinical Site Partners, LLC DBA Flourish Research (Winter Park, FL); K2 Medical Research Maitland LLC, Main Office (Maitland, FL)
- Distance to nearest recruiting site
- ~5 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
NCT07282600
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest sites: Clinical Site Partners, LLC dba Flourish Research (Winter Park, FL); Adult Medicine of Lake County, Inc. (Mt. Dora, FL)
- Distance to nearest recruiting site
- ~5 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
NCT07353931
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Conquest Research (Winter Park, FL)
- Distance to nearest recruiting site
- ~5 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
NCT07037433
- Phase 3
- Ages 45 to 99 years
- Sex: All
Nearest sites: West Orange Endocrinology (Ocoee, FL); Winter Haven Hospital (Winter Haven, FL)
- Distance to nearest recruiting site
- ~10 mi (city-level)
- Recruiting sites
- 5 sites within 50 mi
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
NCT07654374
- Phase 3
- Ages 18 to 79 years
- Sex: All
- Accepts healthy volunteers
Nearest sites: ACCOMPLISH-2 Research Site (Ocoee, FL); ACCOMPLISH-2 Research Site (Leesburg, FL)
- Distance to nearest recruiting site
- ~10 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
NCT06897475
- Phase 2
- Ages 18 to 75 years
- Sex: All
Nearest site: Oviedo Medical Research (Oviedo, FL)
- Distance to nearest recruiting site
- ~14 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
NCT07321886
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Adult Medicine of Lake County, Inc. (Mt. Dora, FL)
- Distance to nearest recruiting site
- ~24 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
NCT07743450
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: AURORA-2 Clinical Site (The Villages, FL)
- Distance to nearest recruiting site
- ~45 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
NCT07743463
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: AURORA-1 Clinical Site (The Villages, FL)
- Distance to nearest recruiting site
- ~45 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
NCT07351058
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Progressive Medical Research (Port Orange, FL)
- Distance to nearest recruiting site
- ~48 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease
NCT07843472
- Phase 3
- Ages 40 years and older
- Sex: All
Nearest site: Progressive Medical Research (Port Orange, FL)
- Distance to nearest recruiting site
- ~48 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity
NCT07843498
- Phase 3
- Ages 18 years and older
- Sex: All
Nearest site: Progressive Medical Research (Port Orange, FL)
- Distance to nearest recruiting site
- ~48 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining an Obesity clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.